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ABSTRACT. Margins are used in radiotherapy to assist in the calculation of planning
target volumes. These margins can be determined by analysing the geometric
uncertainties inherent to the radiotherapy planning and delivery process. An important
part of this process is the study of electronic portal images collected throughout the
course of treatment. Set-up uncertainties were determined for prostate radiotherapy
treatments at our previous site and the new purpose-built centre, with margins
determined using a number of different methods. In addition, the potential effect of
reducing the action level from 5 mm to 3 mm for changing a patient set-up, based on
off-line bony anatomy-based portal image analysis, was studied. Margins generated
using different methodologies were comparable. It was found that set-up errors were
reduced following relocation to the new centre. Although a significant increase in the
number of corrections to a patient’s set-up was predicted if the action level was
reduced from 5 mm to 3 mm, minimal reduction in patient set-up uncertainties would
be seen as a consequence. Prescriptive geometric uncertainty analysis not only supports
calculation and justification of the margins used clinically to generate planning target
volumes, but may also best be used to monitor trends in clinical practice or audit
changes introduced by new equipment, technology or practice. Simulations on existing
data showed that a 3 mm rather than a 5 mm action level during off-line, bony
anatomy-based portal imaging would have had a minimal benefit for the patients
studied in this work.
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Accurate definition of target volumes is fundamental
to the radiotherapy treatment planning process.
Generally, a margin is added to the gross tumour
volume (GTV) to account for subclinical disease and so
create a clinical target volume (CTV). A further margin is
then added to account for geometric uncertainties,
including patient set-up errors, to create the planning
target volume (PTV). A description of the relationship
between these different volumes is presented in
International Commission on Radiation Units and
Measurements (ICRU) 50 and 62 publications [1, 2].
Following the ICRU recommendations, a number of
authors have proposed methodologies for determining
target volume margins. Van Herk et al [3] proposed a
method in which the margins ensure that 90% of patients
receive an equivalent uniform dose (EUD) of at least 98%
(known as the Van Herk method from here on). In 2003,
the British Institute of Radiology (BIR) published
‘‘Geometric Uncertainties in Radiotherapy: Defining the
Planning Target Volume’’ [4], in which the source of many
geometric uncertainties were identified and used to
generate margins in order that the CTV is covered in 90%
of cases (known as the BIR method from here on). A
number of techniques for generating the required
margins from geometric uncertainties have been the
subject of review [5].
Part of the dataset necessary to determine geometric
uncertainties, and hence the required margins, can be
obtained using electronic portal images (EPIs) of the
treatment fields. By comparing the digitally recon-
structed radiograph (DRR), calculated from the therapy
CT scan, with the EPI data, an assessment of the accuracy
of each delivered field can be made [6]. Processes
designed to support the systematic analysis and review
of patient set-up in this way have been described in the
literature [7, 8].
It has been reported [4] that online imaging and
reactive patient repositioning during radiotherapy can
significantly improve treatment accuracy and reprodu-
cibility, and potentially lead to smaller margins around
the target volume. There is, however, a requirement that
the set-up errors, both random and systematic, are
evaluated. It is likely that the set-up errors will vary
depending upon the treatment site and technique,
immobilization equipment used, departmental practice,
and even the age and quality of the imaging and
treatment machines being used. Once established, these
data can be used both as a measure of the quality of the
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treatment delivery at any one time, and as a means to
monitor and confirm changes introduced by the use of
new equipment or treatment techniques.
The aim of this work is to find set-up accuracies at our
previous site (Belvoir Park Hospital (BPH)), and then at
the new Northern Ireland Cancer Centre (NICC) follow-
ing transfer of services in March 2006. We report on the
application of the BIR method [4] to determine margins
for conformal prostate radiotherapy and compared the
results with those using the Van Herk method [3].
Finally, to investigate how the set-up uncertainties
may be improved, and potentially lead to a reduction in
target volume margins, the portal imaging data gathered
were used to predict the impact of a 3 mm, rather than
the current 5 mm, action level on the calculated set-up
uncertainties.
Methods and background
Relocation of the clinical radiation oncology service
In March 2006, the Northern Ireland radiation oncol-
ogy clinical service was relocated from BPH to a new
purpose-built facility at the NICC. This saw a significant
replacement and upgrade in radiotherapy equipment,
including linear accelerators, simulators and imaging
equipment. However, for the patients undergoing con-
formal external-beam prostate radiotherapy in this
study, the main treatment parameters were identical at
both sites. This included (i) treatment position (supine),
(ii) immobilization (knee rest and ankle stocks), (iii)
planned beam arrangement (a three-field class solution
anterior and a pair of parallel-opposed wedged laterals),
(iv) prescription (70 Gy in 35 fractions using 15 MV
photons) and (v) portal imaging protocol.
At BPH, all patients were imaged on a Siemens
Emotion 6 CT scanner (Siemens Medical Systems,
Forcheim, Germany) with 5 mm spaced slices and
planned on a Theraplan Plus (TPP) v3.8 (Nucletron BV,
Veenendal, the Netherlands) external beam treatment
planning system. Portal images for 25 patients were
analysed, after acquisition using an aS500 amorphous
silicon electronic portal imaging device (EPID) on one of
two Varian 2100CD Clinacs (Varian Medical Systems,
Palo Alto, CA). Before treatment, all plans were verified
on a Simulix simulator (Nucletron BV.).
At the NICC, patients underwent CT scans either on
the Siemens Emotion 6 (moved from BPH) or on a new
GE Lightspeed RT CT scanner (GE Medical Systems,
Milwaukee, WI), again using 5 mm spaced slices.
Planning is now performed on an Oncentra MasterPlan
(OMP) v1.4sp4 system (Nucletron B.V.). Portal images
for a further 25 patients were analysed, having been
acquired using an aS500 EPID on one of two newer
Varian 2100CD Clinacs. Before treatment, plans were
verified on an Acuity simulator (Varian Medical Systems
Inc.).
Portal imaging
The portal imaging protocol implemented at both sites
is as follows: anteroposterior (AP) and left–right/right–
left lateral double-exposed electronic portal images
(EPIs) are acquired during the first three fractions of
the treatment course (days 1–3), and then AP and lateral
EPIs are acquired on a weekly basis. Both laterals were
imaged on day 1 and then alternated between left–right
and right–left on each subsequent imaging day. A 2 cm
margin was applied to the treatment field jaw settings for
the double-exposed part of the image. Each EPI was
compared with the DRR generated from the therapy CT
scans, using Varis v7 (Varian Medical Systems Inc.) off-
line image matching tools. An action level of 5 mm was
defined for this process. A shift in the patient set-up
instructions was applied when a systematic deviation
greater than the 5 mm action level was observed
between the DRR and portal images, and would be
applied following delivery of the first three fractions. If a
set-up offset greater than 5 mm was observed during the
weekly image analysis, a repeat image was scheduled; if
the offset was reproduced, a correction was applied to
this set-up (an average of the weekly displacement and
the repeat displacement).
Determination of geometric uncertainties
BIR 2003: equation and related uncertainties
The PTV as described by ICRU [1, 2] is a geometrical
concept. It is defined by taking into consideration the net
effect of all the possible geometrical variations in order to
ensure that the prescribed dose is actually delivered to
the CTV [1]. The BIR method for calculating a CTV–PTV
margin [4] separates errors into those introduced
through the treatment preparation stage, in which errors
will be propagated systematically through the course of
the treatment, and the treatment execution errors that
result from the day-to-day uncertainties of set-up, organ
shape and motion. This method also takes into account
the effect of different treatment beam configurations.
The systematic Gaussian error (S) is defined as being
composed of the doctor delineation error, motion error,
phantom transfer error and systematic set-up error,
summed in quadrature. A random Gaussian error
(treatment execution error — s) is composed of the
random set-up error, motion error and beam penumbra,




zazbzb s  sp
  ð1Þ
where S is the systematic error, s is the treatment
execution error, b is the planning parameter (to account
for different treatment beam configurations), sp is the
beam penumbra width, a is the linear treatment planning
beam algorithm error and b is the linear breathing error
(i.e. the uncertainties to the target position associated
with a patient’s respiration cycle).
The magnitude of the uncertainty in delineating the
target is related to the imaging modality used and the
level of expertise in interpreting the image and outlining
the target. Within the BIR (2003) handbook, it was
concluded that the ‘‘gold standard’’ imaging modality
was MRI alongside CT. With these modalities, it was
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proposed that, for prostate radiotherapy treatments, a
doctor delineation error of 2 mm in all directions could
be used. For this work, we reviewed values presented in
the literature and applied the value used by Rasch et al
(in 1999) [9] on the basis that it most closely follows what
happens in clinical practice in our centre.
Prostate motion error has been studied by a large
number of authors [10–13] and was discussed in detail in
the BIR (2003) handbook [4]. A review by Langen and
Jones [10] showed variability between studies, although
they reported that prostate motion was generally of the
same magnitude for each study: 0.6¡0.7 mm,
20.4¡3.9 mm and 20.2¡3.2 mm for lateral, AP and
superior-inferiormotion, respectively. The values attained
by the BIR handbook were used for the motion error.
Set-up errors can be determined by systematic analysis
of EPIs andDRRs. It is recommended in the BIR handbook
that information from at least 20 patients should be used.
Set-up errors may range from 1.0–4.0 mm [14]. In this
work, imaging data from the two sets of 25 patients were
analysed, so giving 50 sets of 19 EPIs that were matched to
the reference DRRs. Offsets in the left, right, superior,
inferior, anterior and posterior directions were each
recorded individually. From these measurements, the
standard deviation of the systematic set-up error and
mean standard deviation of treatment set-up errors were
determined. Portal images show combined effects of set-
up errors and phantom transfer error, but not delineation
error or organ motion error, because the organ is not
visible in the portal image. The calculation in the BIR
handbook reflects this by including the systematic set-up
error but not the transfer error within the combined
systematic set-up error. The calculations for our centres,
both BPH and NICC, also assumes that the phantom
transfer error is constant and contained within the
systematic set-up error, as each dataset was collected
over a relatively short period of time.
An action level was specified at 5 mm. This produces a
top hat function for the distribution of set-up errors, with
a corresponding standard deviation of 1/!3 times the
action level (1/!3 6 5 mm 5 2.9 mm in our case).
However, on analysis of the changes made to the
patient’s set-up instructions in this study, it was
identified that the actual action level being observed
was closer to 4 mm. This was because, whenever
systematic uncertainties were revealed to be 4 mm, the
patient’s set-up was routinely corrected at the clinician’s
discretion. Therefore, an action level of 4 mm with a
corresponding standard deviation of 4 mm/!3 for the
top hat distribution function was used in the analysis, as
it better described the protocol used in clinical practice.
The treatment planning system (TPS) algorithm error is
a linear systematic uncertainty. If the width between the
high-dose levels in the penumbrae of treatment beams
calculated and displayed by the TPS is larger than that
delivered, there will be a systematic under-dosing of the
CTV and PTV. Therefore, the margin around the CTV
should be increased to account for this. Water tank profile
measurements of a 15MVphoton beamwith a field size of
106 10 cm2 at 10 cm deep with a source to skin distance
(SSD) of 90 cm, taken during commissioning, were used
to find this parameter. The measured profile widths at the
90% dose level were compared with calculations gener-
ated on the treatment planning systems.
The magnitude of the beam penumbra will have an
effect on the field size required and the probability of
CTV coverage. The photon penumbra error may be
measured by dividing the distance between the 10% and
the 90% level of a single beam at a typical treatment
depth by 2.56. (This is derived by assuming that the
penumbra dose is described by an error function.) Profile
measurements of a 15 MV photon beam with a field size
of 10 6 10 cm2 at 10 cm deep with SSD 90 cm and at
20 cm deep with SSD 80 cm, taken during commission-
ing, were used to find this parameter.
The planning parameter, which accounts for the effect
that the number of beams and geometry can have on
overall beam penumbra, was provided by the BIR (2003)
handbook for the class solution of treatment beams used
at our centre (anterior and two wedged lateral beams).
Although it has been suggested that patients’ breath-
ing may influence prostate movement during a radio-
therapy treatment [15], it is possible that it is related to
the immobilization technique and equipment used [16].
Therefore, this parameter was set to zero for all
calculations in this study.
Van Herk method: equation and related
uncertainties
A second method for determining geometric uncer-
tainties was also investigated. This method is simpler
than the BIR method and has been used in a number of
studies [17–19]. Like the BIR method, it uses the
combined systematic error and the treatment execution
error but does not consider the penumbra, breathing,
motion, planning parameter or the algorithm error
explicitly. The equation is given by:
CTV PTV margin~ 2:5
X
z 0:7s ð2Þ
This margin ensures that 90% of patients have an EUD of
98%. The delineation and prostate motion errors (SI, AP
and lateral) were defined by Rasch et al [9] and Van Herk
et al [20]. The set-up uncertainties were taken from
measurements made by Bel et al [21].
Tolerance reduction
Further analysis of the NICC data was performed with
respect to the 5 mm action level used. First, any
corrections that had been made to a patient set-up were
removed from the EPI data so that it represented the
daily set-up without a correction strategy in place [22].
Each patient dataset was then re-analysed and corrected
based on a 3 mm action level (i.e. whenever a systematic
displacement was greater than 3 mm, a correction was
applied to all subsequent data points). If the remaining
data points revealed a systematic set-up that exceeded
the action level, again all subsequent data points were
corrected. Although this does not replicate exactly the
process that would be used in practice (a weekly ‘‘out of
tolerance’’ set-up would require an image acquisition the
following day to confirm a systematic set-up variation), it
does provide an estimate of the effect of size of the action
level on the set-up uncertainties. It can be used to help
predict any increase in the number of changes to the
C K McGarry, V P Cosgrove, V A L Fleming et al
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patient’s set-up during the course of their treatment as a
consequence of this lower action level.
Results
Geometric uncertainties used to generate margins
All uncertainties used in the calculations are given in
Table 1. These include the planning parameter, the
breathing error, the doctor delineation error and the
motion error. The value obtained for the algorithm error
(a) for the TPP system was 21.5 mm, whereas for the
OMP system it was 20.7 mm. These values are negative
because the 90% isodoses calculated were less than those
measured in the water tank. At 10 cm and 20 cm deep,
the measured 90–10% penumbra was 11 mm and 16 mm,
respectively. Therefore, the average photon penumbra
width (sp; beam penumbra divided by the 2.56 error
function) used was rounded to 5.0 mm, as this closely
follows the value used in the BIR 2003 handbook.
Magnitude of uncertainties
Table 2 illustrates the set-up uncertainties calculated
in this work, and are given along with values calculated
in the BIR (2003) handbook and those reported by
Enmark et al [19]. The reasons for using this publication
were that it was recent, it used CT for delineation and it
closely followed how patients are set up at our centre
(using external markers).
Figure 1 shows histograms comparing the calculated
uncertainties at BPH and those at NICC. There is more
spread seen for BPH than NICC, which is reflected in the
larger set-up uncertainties seen in Table 2.
Treatment margins
Table 3 shows the required CTV–PTV margin calcu-
lated for the two sites using the BIR method, along with
given values from the literature. It should be noted that,
in the BIR 2003 example, MRI was used to delineate the
prostate and all delineation uncertainties were set to
2 mm. At our centre, (and in Enmark et al [19]), CT alone
is used and therefore the values given in Table 1 were
used as the doctor delineation error.
Table 4 shows the CTV–PTV margins generated using
the Van Herk method, along with examples from the
literature for comparison; where applicable, the same
measured uncertainties were used.
Table 5 shows the possible effects that different
correction strategies would have on generating CTV–
PTV margins using the BIR method. The correction
strategy with a protocol of no correction was simulated
by replacing any shifts applied through the original
5 mm correction strategy and then using the resulting
set-up errors (Table 2) to generate the margins. All other
components in the equation were unchanged. The set-up
errors from the simulated 3 mm action level in Table 2
were also used to generate margins for comparison
(Table 5). Also shown are the margins generated had
there been no (zero) set-up errors.
Discussion
It can be seen from Table 2 that the random errors
were consistent for both BPH and NICC patients; as
identical techniques were used to set up patients for
imaging and treatment (i.e. immobilization, use of skin
tattoos), this was expected. However, there appears to be
a reduction in the calculated systematic error and this
improvement is more clearly demonstrated in Figure 1.
The data provide evidence that the transfer of the clinical
service was achieved without detriment to the accuracy
of the radiotherapy treatment. Analysis of the geometric
accuracy of radiotherapy treatment was prudent, as
more than one device (CT scanners, treatment planning
system and linear accelerators) changed following the
move to the new radiotherapy centre. The reduction in
the systematic error may be a consequence of the use of
new imaging and treatment delivery equipment.
The uncertainties reported here are similar to those
quoted in the BIR 2003 handbook and are lower than
those quoted by Enmark et al [19] for conformal
radiotherapy. Hurkmans et al [14] suggest that random
and systematic set-up errors of 2.5 mm can be consid-
ered to be ‘‘state-of-the art’’ for prostate treatment
techniques.
Table 3 lists the CTV–PTV margins calculated from the
uncertainties when following the BIR method. Although
an improvement was observed in systematic set-up
errors for the NICC data, this did not lead to a significant
reduction in the margin for all orientations. One of the
reasons for this was that the TPP algorithm error had a
larger effect in reducing the margin. In addition, the
doctor delineation error and motion errors are dominant
in the creation of these margins. This is demonstrated in
Table 5 by setting the set-up uncertainties to zero and
calculating the margins using the uncertainties in
Table 1. The greatest margin reduction due to a reduc-
Table 1. Geometric uncertainties obtained from the literature [referenced] or measured (M) using a 15 MV 106 10 cm2 photon
beam
Uncertainty Lateral (mm) Superior-inferior (mm) Anteroposterior (mm)
Doctor [9] 1.7 2.8 2.0
Motion [4] 1.0 2.5 3.0
Breathing [4] 0 0 0
Phantom transfer [4] 3.0 3.0 3.0
Planning parameter [4] 1.04 1.64 1.44
Algorithm TPP/OMP (M) 21.5/20.7 21.5/20.7 21.5/20.7
Penumbra (M) 5.0 5.0 5.0
TPP, Theraplan Plus; OMP, Oncentra MasterPlan.
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tion in set-up uncertainties was seen for the lateral
direction, and is the direction for which the doctor
delineation error and motion contribution were smallest.
Table 4 shows that the margins generated by the van
Herk method were similar to those using the BIR
method, although they are between 0.8 mm and
2.7 mm larger. A further formula suggested by Van
Herk et al [23] is:
CTV-PTV margin~ 2:5
X
z 0:7s{ 3mm ð3Þ
The CTV–PTV margins found using this formula are less
than those generated with the BIR method by between
0.3 mm and 2.2 mm. The use of either Equation 2 or
Equation 3 is much simpler than Equation 1, as the
planning parameter, algorithm and penumbra errors are
not included. The planning parameter is beam orienta-
tion dependent and, with the advancement of varying
intensity-modulated radiotherapy class solutions, may
become more difficult to quantify. Importantly, both Van
Herk et al methodologies [3, 23] reveal a margin
reduction in the NICC data relative to that of the BPH.
A 10 mm CTV–PTV margin in all directions for
prostate radiotherapy is a widely reported standard
[23–28], although some use this margin along with a
reduction to 6–8 mm at the posterior border [29–31].
Margins used in this more recent literature are more
consistent than those reported in the review by Wu et al,
[32], where margins ranged from 5.6–17.5 mm, 7–20 mm
and 6–20 mm in the lateral, superior-inferior and AP
directions, respectively. At our centre, a margin of
10 mm is currently used in all directions. The main
reason for selecting this margin is its use in clinical trials,
such as the RT01 trial, the emerging results of which
indicate that this margin is clinically acceptable [33].
Also, it has been postulated [23] that tumour control
probability (TCP) does not decrease significantly when
reducing margins from 14 mm to 10 mm. However, a
further reduction below 10 mm may result in a marked
decrease in TCP. Hence, the use of 10 mmmargins rather
than those calculated will allow a reduction in dose to
critical structures while maintaining an acceptable TCP.
Table 2 indicates that there are advantages in using an
action level of 5 mm relative to a protocol of no
correction to control systematic set-up uncertainties,
particularly in the superior-inferior direction. However,
the data seem to imply that there would not be much
benefit in reducing the action level further to 3 mm. This
may be due to the fact that a 5 mm action level was not
scrupulously observed in practice, with systematic
uncertainties of 4 mm being regularly adjusted at the
Table 2. Systematic and random errors for BPH and NICC (5 mm action level) compared with the example in the BIR (2003)
handbook [4] and Enmark et al [19]
Systematic (mm) Random (mm)
Lateral Superior-inferior Anteroposterior Lateral Superior-inferior Anteroposterior
Audit at BPH 3.3 2.4 2.7 2.5 1.7 1.8
Audit at NICC 2.7 2.2 2.0 2.3 1.7 1.7
BIR (2003) 1.2 3.0 1.7 2.4 2.3 2.2




2.9 2.9 2.1 2.1 1.5 1.6
NICC with 3 mm
correction strategya
2.7 2.1 2.0 2.6 1.7 1.9
BPH, Belvoir Park Hospital; NICC, Northern Ireland Cancer Centre; 3DCRT, three-dimensional conformal radiotherapy.
aPredicted errors for the NICC data are also shown based on a ‘‘a protocol of no correction’’ and ‘‘3 mm correction strategy’’
simulation.
Figure 1. Histogram of displace-
ments (all directions) at (a) Belvoir
Park Hospital (BPH) and (b) Northern
Ireland Cancer Centre (NICC). Data
are pooled in such a way that a
positive value is assigned to a treat-
ment beam being posterior, super-
ior or left with respect to the
reference image for the anteropos-
terior, superior-inferior or lateral
displacements, respectively.
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doctors’ discretion. However, it is important to consider
that a 3 mm action level would result in an increase in
the number of images acquired during the patients’
treatment (to confirm a systematic deviation), as well as
an increase in the number of changes made to the
patients’ set-up instructions (10 of the 25 patients were
shifted for the 5 mm action level compared with 23 of the
25 patients that would have had to be shifted if the 3 mm
action level were observed). This could be analysed more
thoroughly by using a 3 mm action level with a cohort of
patients. Nevertheless, Table 5 shows that when sys-
tematic or random uncertainties are set to zero, the
margins required are still relatively large. This would
seem to indicate that changing an action level would
have less of an impact than strategies to minimize the
doctor delineation or motion uncertainties.
All set-up errors in this work have been attained
through analysis of data that utilize an off-line imaging
protocol, using bony anatomy rather than the tumour,
for image matching. Daily online imaging using soft-
tissue information or seeds should help to reduce
margins further [12, 19, 32, 34–36], as the set-up
uncertainty and motion error may be contained within
a single uncertainty value. Investment in hardware and
resources is required to achieve this. Our work suggests
that a 3 mm action level would be of minimal benefit
when using off-line bony anatomy-based matching, but
this or an even smaller value may be more appropriate
for use with an online tumour-based protocol.
Conclusions
Systematic and random set-up errors, determined
from EPIs, have been used to investigate geometric
uncertainties of localized prostate cancer radiotherapy.
The BIR method includes a number of parameters, some
of which must be sourced from published literature. The
Van Herk method, although simpler to calculate, was
found to generate larger CTV–PTV margins. Margins
used clinically still tend to be based on legacy clinical
practice or adopted from clinical trial protocols. The
acceptability of these in terms of TCP and normal tissue
complication probability outcomes does not seem to
indicate that margins should be increased based on the
margin calculations. However, the greatest advantage in
using the calculation techniques may be for monitoring
trends in clinical practice or audit changes introduced by
new equipment, technology or practice. As such, the
choice of the method to use may be less important than
using a particular method in a consistent manner.
On re-analysing the EPI data with a simulated 3 mm
action level, the indications were that this reduced
Table 3. CTV–PTV margins generated following the BIR method
CTV–PTV margin (mm)
Lateral Superior-inferior Anteroposterior
Audit at BPH 8.8 11.0 11.3
Audit at NICC 8.3 11.7 11.5
BIR 2003 7.2 12.2 11.2
Enmark et al [19] (3DCRT) 6.4 15.0 12.2
CTV, clinical target volume; PTV, planning target volume; BPH, Belvoir Park Hospital; NICC, Northern Ireland Cancer Centre;
3DCRT, three-dimensional conformal radiotherapy.
Table 4. CTV–PTV margins generated following the Van Herk method
CTV–PTV margin (mm)
Lateral Superior-inferior Anteroposterior
Audit at BPH 11.5 13.3 13.7
Audit at NICC 10.1 13.1 13.1
BIR 2003 8.8 13.3 12.6
Enmark et al [19] (3DCRT) 8.1 15.8 13.4
CTV, clinical target volume; PTV, planning target volume; BPH, Belvoir Park Hospital; NICC, Northern Ireland Cancer Centre;
3DCRT, three-dimensional conformal radiotherapy.
Table 5. CTV–PTV margins generated following the BIR method using the original set-up errors (5 mm correction strategy) and
simulations of ‘‘a protocol of no correction’’ or ‘‘a 3 mm correction strategy’’. Also included are margins had no random or
systematic set-up errors been present
CTV–PTV margin (mm)
Lateral Superior-inferior Anteroposterior
Simulated at NICC (no CS) 8.6 12.5 11.2
Audit at NICC (5 mm CS) 8.3 11.7 11.5
Simulated at NICC (3 mm CS) 8.4 11.4 11.2
Zero setup/random error 4.3 9.7 9.5
CTV, clinical target volume; PTV, planning target volume; NICC, Northern Ireland Cancer Centre; CS, correction strategy.
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tolerance would increase workload (through additional
imaging and increased adjustment to patient set-up)
without realizing a reduction in uncertainties. Therefore,
we believe that a 5 mm action level is adequate for the
bony anatomy-based off-line imaging protocol in use at
our cancer centre.
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